2004•Journal of Anhui Health Vocational & Technical CollegeRequires access

Clinical observation of spironolactone treatment in patients with chronic heart failure of coronary heart disease

Zheng Wang

Open publisher page 0 citations

Abstract

Objective To observe the effect of spironolactone treatment in patients with chronic heart failure of coronary heart disease. Methods 80 patients with chronic heart failure of coronary heart disease were randomly divided into therapy group (40 cases) and control group (40 cases).The patients in control group used mainly diuretil, angiotensin converting enzyme inhibitors( ACEI) , β - adrenoceptor blocking drugs and digitalis. On the basis of the above treatment, patients in therapy group used spironolactone instead of triamterene. Clinical effects were evaluated after three- month treatment. Results The total effectiveness of the therapy group was 92.5% , and the total effectiveness of the control group was 75.0% . There was distinctive difference between the two groups (P0.05). Conclusion Spironolactone can improve the clinical therapy effect obviously.

About this research paper

What this paper is about

Objective To observe the effect of spironolactone treatment in patients with chronic heart failure of coronary heart disease. Methods 80 patients with chronic heart failure of coronary heart disease were randomly divided into therapy group (40 cases) and control group (40 cases).The patients in control group used mainly diuretil, angiotensin converting enzyme inhibitors( ACEI) , β - adrenoceptor blocking drugs and digitalis. On the basis of the above treatment, patients in therapy group used spironolactone instead of triamterene. Clinical effects were evaluated after three- month treatment. Results The total effectiveness of the therapy group was 92.5% , and the total effectiveness of the control group was 75.0% . There was distinctive difference between the two groups (P0.05). Conclusion Spironolactone can improve the clinical therapy effect obviously.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of spironolactone treatment in patients with chronic heart failure of coronary heart disease. Methods 80 patients with chronic heart failure of coronary heart disease were randomly divided into therapy group (40 cases) and control group (40 cases).The patients in control group used mainly diuretil, angiotensin converting enzyme inhibitors( ACEI) , β - adrenoceptor blocking drugs and digitalis. On the basis of the above treatment, patients in therapy group used spironolactone instead of triamterene. Clinical effects were evaluated after three- month treatment. Results The total effectiveness of the therapy group was 92.5% , and the total effectiveness of the control group was 75.0% . There was distinctive difference between the two groups (P0.05). Conclusion Spironolactone can improve the clinical therapy effect obviously.

Key concepts: Medicine, Spironolactone, Heart failure, Digitalis, Internal medicine, Triamterene, Coronary heart disease, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of spironolactone treatment in patients with chronic heart failure of coronary heart disease — Research Paper | ScholarLens